MissionIR Articles
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device
HeartBeam (NASDAQ: BEAT) has received FDA 510(k) clearance for its groundbreaking HeartBeam system, a credit card-sized, cable-free ECG device designed for comprehensive arrhythmia assessment. The system enables patients to record high-fidelity heart signals from three directions during symptoms, with data transmitted to physicians for timely review and action. This milestone marks the first FDA-cleared device…
-
MissionIRNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) (NEO: SUNN) (FSE: GY2) Releases Results of Annual General and Special Meeting
SolarBank (NASDAQ: SUUN) (CSE: SUNN) (NEO: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., has announced the results of its 2024 annual general and special meeting of shareholders. The nominees listed in the management information circular for the…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned to Capitalize on the Rise of AI
McEwen Mining (NYSE: MUX) (TSX: MUX) is poised to benefit amid the growing use of artificial intelligence (“AI”) in everyday life activities. As the use of AI tools trends upward, such as in the job application process among countless others, “The companies behind those AI tools could be basking in the limelight of their innovations, but…
-
MissionIRNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Integrates with X Corp, Redefining Social Media Advertising
Thumzup (NASDAQ: TZUP), has officially integrated its platform with Elon Musk’s X Corp (formerly Twitter), granting advertisers access to X’s 535 million monthly active users. This integration empowers Thumzup to deliver real-time, locally targeted campaigns that connect brands with users who authentically promote their products. CEO Robert Steele highlighted the partnership as a transformative step…
-
MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Secures Three-Year State Government Contract for Outfitter Satellite Connectivity Services
NextPlat (NASDAQ: NXPL, NXPLW) announced that its U.S.-based connectivity division, Outfitter Satellite Inc., has been awarded a three-year contract by a U.S. state government to provide satellite connectivity services. The agreement includes satellite airtime service plans and hardware to support the government workforce during remote operations and natural disasters, with an option to extend for two…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Subsidiary Expands Midwest Reach with Broadway Ford Truck Center Partnership
Mullen Automotive (NASDAQ: MULN) announced that its subsidiary, Bollinger Motors, has partnered with St. Louis-based Broadway Ford Truck Center as an official dealer, enhancing its Midwest presence. Bollinger’s all-electric Class 4 commercial truck, the B4 Chassis Cab, which features a 158-kilowatt-hour battery and fleet-focused design, began deliveries in October. Broadway Ford Truck Center’s President, Dennis…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Highlights Commercial Success of Annealing Quantum Computing on Fox Business
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing, announced that CEO Dr. Alan Baratz recently appeared on Fox Business’ Making Money with Charles Payne, discussing the state of the quantum industry and D-Wave’s advancements in the space. Dr. Baratz emphasized that D-Wave operates the world’s largest quantum computers, which are being used now…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for brain and central nervous system cancers, will host a Virtual Analyst & Investor Day on December 11 from 11:30 a.m. to 1 p.m. ET. The event will feature presentations by the company’s leadership team, including CEO John Climaco, Chief Medical Officer Dr. Sandra Silberman, and…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) CEO Highlights Innovations in Neurodegenerative Drug Development on Today’s Marketplace
Annovis Bio (NYSE: ANVS), a leader in developing treatments for neurodegenerative diseases, was recently featured on Today’s Marketplace in an exclusive interview with Dr. Maria Maccecchini, Founder, President, and CEO. Dr. Maccecchini detailed Annovis Bio’s groundbreaking drug development targeting toxic proteins responsible for nerve cell damage in Alzheimer’s and Parkinson’s, as well as the company’s…
-
MissionIRNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Announces Integration with X Corp. to Revolutionize Digital Advertising
Thumzup Media Corp. (NASDAQ: TZUP) plans to integrate its innovative ad tech platform with X Corp. (formerly Twitter), expanding its reach to over 535 million monthly active users. This integration, expected by January 2025, complements Thumzup’s existing presence on Instagram, allowing unified campaign management, enhanced audience targeting, and user monetization through authentic brand endorsements. CEO…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised to Tap Explosive Growth of AI Industry
McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned for opportunity as artificial intelligence is rapidly reshaping the landscape of economies around the world. “Estimates indicate that generative AI alone will triple its growth to a total market value of $1.3 trillion in the next decade… As most investors know by now, there is a surge…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Share Clinical and Strategic Updates
Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for…
-
MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Reports Strong Financial Performance and New Contracts, Expanding Footprint in US and Israel
SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Nine-Month Financial Results and Business Update
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing innovative biological products targeting inflammation and immunology (“I&I”) and offering contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices division, released its financial results for the nine months ending Sept. 30, 2024. The announcement highlights the company’s progress in advancing its I&I-focused pipeline…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights American-Made Battery Production at Fullerton Facility
Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, provided an update on its Fullerton, California, battery operations, which focus on producing next-generation battery packs and modules domestically. This initiative supports Mullen’s commitment to zero emissions and reducing reliance on imported battery components. CEO and Chairman David Michery emphasized the company’s mission to transition to American-made…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Poised for Opportunity Amid Rising Demand for ‘AI Metals’
McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the evolution of artificial intelligence (“AI”), spotlighting Geoffrey Hinton’s (“the Godfather of AI”) award of the Nobel Prize in Physics alongside John Hopfield for their groundbreaking work that triggered the development of machine learning, the science behind AI as we know…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Paving the Way for NDA Submission
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing transformative therapies for neurodegenerative disorders, including Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently achieved a significant milestone in its drug development process. In early October, the company held a meeting with the U.S. Food and Drug Administration (“FDA”), where it received…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Globavend Holdings Limited (NASDAQ: GVH) Reports 42.5% Revenue Growth for Fiscal 2025
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway
- Forward Industries Inc. (NASDAQ: FWDI) Announces Fiscal First Quarter 2026 Financial and Operational Results, and an Update on the SOL Treasury Strategy
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) to Launch Mudra Experience Studio Developer Platform